Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01644110
Title Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF (POMINC)
Acronym POMINC
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Ulm
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.